Kate Byth
Senior Drug Discovery Leader | Oncology & Immunology Value Creator | Translational Strategy Expert | Volunteer & Book Group Founder
- Role
- VP, Head of Biology at Enanta Pharmaceuticals
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Kate Byth
Strategic drug discovery leader with 25+ years of experience translating first-in-class immunology and oncology programs from concept to clinic. Proven success in biomarker strategy, translational planning, and leading IND-enabling efforts resulting in successful regulatory filings and acquisitions. Exceptional communicator and mentor with deep experience managing cross-functional teams in startups and large pharmaceutical organizations.CORE COMPETENCIESTranslational Science & IND Strategy, Biomarker Development & PK/PD Modeling, Target Identification & Validation, Program & Portfolio Leadership, Cross-Functional Team Leadership, External Partner Engagement & Fundraising, Strategic Planning & Value Creation
Experience
VP, Head of Biology
Sep 2025 — Present
Education
University of Cambridge
MA Hons, Cantab, Natural Sciences
1986 — 1989
University of Cambridge
PhD, Immunology
1989 — 1994
Skills
- Molecular Biology
- Cell Cycle
- Clinical Development
- Translational Research
- Cell
- Pharmaceutical Industry
- In Vitro
- Pharmacology
- Biomarkers
- Immunology
- Life Sciences
- Biotechnology
- Translational Medicine
- Drug Development
- Cancer
- Clinical Trials
- Drug Discovery
- Apoptosis
- Proteomics
- Oncology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.